Detalhe da pesquisa
1.
Antiemetic medication efficacy during EPOCH and R-EPOCH treatment.
J Oncol Pharm Pract
; 27(7): 1691-1698, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33092500
2.
Updated report on incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant.
J Oncol Pharm Pract
; 25(5): 1053-1057, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29651918
3.
Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre.
Br J Haematol
; 185(2): 363-366, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30028000
4.
Incidence of infusion-site reactions associated with peripheral intravenous administration of fosaprepitant.
Support Care Cancer
; 22(6): 1461-6, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24402412
5.
Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders.
Blood Adv
; 7(14): 3431-3434, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877766
6.
Biweekly gemcitabine and low-dose cisplatin in the treatment of locally advanced or metastatic pancreatic cancer patients: a single institute experience.
Med Oncol
; 33(1): 4, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26696390